James Hardie Industries Plc - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by James Hardie Industries Plc on July 27, 2018, covering the month of July 2018. The filing serves as a notification of the company's First Quarter Fiscal Year 2019 (Q1FY19) results, referenced in Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a cover sheet and legal disclosure rather than a detailed financial statement. The actual financial results are contained in the attached "Q1FY19 Results Notification" (Exhibit 99.1), the content of which is not included in the source text.
Material Changes
The filing text does not provide data to compare current period performance against prior periods. No specific material changes in financial condition or operations are detailed in the provided excerpt.
Guidance, Outlook, and Risks
The document contains an extensive "Forward-Looking Statements" section cautioning investors against undue reliance on future projections. Key risks and uncertainties identified include:
- Asbestos Liabilities: Risks related to prior asbestos manufacturing, contributions to the Asbestos Injuries Compensation Fund (AICF), potential shortfalls in the fund, and currency exchange impacts on recorded liabilities.
- Legal and Regulatory: Exposure to product liability, environmental, consumer class action, and other legal proceedings.
- Market Conditions: Dependence on US and Asia Pacific housing markets, new home construction, renovations, and economic conditions such as unemployment and interest rates.
- Operational Risks: Integration of Fermacell, supply and cost of raw materials, competition, and potential plant closures or capital expenditure projects.
- Financial Risks: Ability to renew credit facilities, tax law changes, and warranty provision adequacy.
Investor Verification Checklist
- Review the full text of Exhibit 99.1 ("Q1FY19 Results Notification") for specific revenue, earnings, and cash flow figures.
- Verify the current status and funding adequacy of the Asbestos Injuries Compensation Fund (AICF).
- Assess the impact of currency exchange rates on the company's reported liabilities and earnings.
- Monitor updates on the integration of the Fermacell acquisition.
- Check for any new developments in pending legal proceedings or regulatory matters.